PMID: 2485083Jan 1, 1989Paper

High dose intravenous gammaglobulins in autoimmune disorders: mode of action and therapeutic uses

Autoimmunity
A Etzioni, S Pollack

Abstract

Gammaglobulins administered intramuscularly have been used for more than 40 years to treat antibody deficiency states. In the last decade intravenous preparations were developed. They do not aggregate and contain IgG molecules with intact recognition and effector functions. These compounds are safe and only minor side effects were reported even when high doses were given. While studying their effect when given in high doses to hypogammaglobulinemic patients, an accidental finding was observed regarding their beneficial effect in idiopathic thrombocytopenic purpura (ITP). This observation led to many studies looking at the effect of high dose gammaglobulin in several other autoimmune diseases. While the effect in acute ITP is well established, there are encouraging reports in respect to the effect of intravenous gammaglobulin in many other disorders, but no final conclusion can be drawn due to the small numbers of cases studied. The mechanism by which intravenous gammaglobulin exerts its function is still unclear. It may work through the Fc receptor in the reticuloendothelial system, as an immunoregulator agent or interact in the idiotype-antiidiotype network. Intravenous gammaglobulin seems to be an important therapeutic tool i...Continue Reading

References

Jul 1, 1985·Acta paediatrica Scandinavica·E HeinzeK Zuppinger
Aug 7, 1986·The New England Journal of Medicine·J W NewburgerS P Sanders
Feb 1, 1987·The Journal of Clinical Investigation·D Y LeungR S Geha
May 1, 1987·The Journal of Pediatrics·M NagashimaN Okumura
Feb 1, 1988·The Journal of Pediatrics·J BusselS Fikrig
May 1, 1988·The Journal of Pediatrics·A BallinV Blanchette
Feb 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·Y SultanM D Kazatchkine
Oct 15, 1987·The New England Journal of Medicine·W A McGuireR Hoffman
Nov 1, 1987·The Journal of Pediatrics·F Z Bierman, W M Gersony
Jul 1, 1986·Archives of Internal Medicine·E L ArsuraD Grob
Mar 1, 1986·The Journal of Pediatrics·G KorenR Rowe
Jun 1, 1985·British Journal of Haematology·E A MacintyreA C Newland
Feb 19, 1983·Lancet·B Rowbotham, R L Brearley
Apr 21, 1984·Lancet·A S CrossD Tang
Jul 16, 1983·Lancet·M AriizumiT Momoki
Oct 28, 1982·The New England Journal of Medicine·C VerganiG F Altomare
Oct 1, 1983·British Journal of Haematology·J P ClauvelC Lacombe
May 1, 1984·The British Journal of Clinical Psychology·M JohnstonG L Thorpe
Jun 1, 1984·Blut·G GaedickeD Niethammer
Jan 11, 1988·Physical Review Letters·J AdlerY Zhu

❮ Previous
Next ❯

Citations

Aug 1, 1992·Acta Neurologica Scandinavica·S D CookP C Dowling
Feb 1, 1996·Journal of Neuroimmunology·D A TamR T Leshner
Mar 16, 1995·International Journal of Cancer. Journal International Du Cancer·D A Chow
Jan 1, 1995·Journal of the American Academy of Dermatology·A K GuptaD N Sauder
Jul 1, 1991·European Journal of Pediatrics·A EtzioniY Tal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

© 2022 Meta ULC. All rights reserved